Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

HKG:6990 Revenue

Sichuan Kelun-Biotech Biopharmaceutical had revenue of 978.34M CNY in the half year ending June 30, 2026, a decrease of -29.25%. This brings the company's total for the last twelve months to 2.09B, up 38.99% year-over-year. In the year 2025, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 2.06B with 6.46% growth. That makes Sichuan Kelun-Biotech Biopharmaceutical the 14,379th largest company in the world by revenue and 849th in Hong Kong.

• Revenue (ttm): 2.09B CNY
• Revenue Growth: +38.99%
• P/S Ratio: 46.97
• Revenue / Employee: 906.88K CNY
• Employees: 2,300
• Market Cap: 106.75B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• The United States of America 1.31B 63.9%
• The PRC 571.20M 27.8%
• Switzerland 168.69M 8.2%
• Other Countries 3.31M 0.2%

Fiscal year ended Dec 31, 2025 See the full HKG:6990 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.06B	124.88M	6.46%
Dec 31, 2024	1.93B	392.55M	25.48%
Dec 31, 2023	1.54B	736.56M	91.62%
Dec 31, 2022	803.93M	771.61M	2,387.26%
Dec 31, 2021	32.32M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error